Literature DB >> 30258849

Corrigendum to "Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively".

Qi Yu1, Changqing Xu2, Wei Yuan3, Chengfeng Wang4, Ping Zhao4, Lianzhen Chen5, Jie Ma6.   

Abstract

[This corrects the article DOI: 10.1155/2017/6495867.].

Entities:  

Year:  2018        PMID： 30258849      PMCID： PMC6146618          DOI： 10.1155/2018/3782512

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


In the article titled “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively” [1], there were errors in the authors' affiliations. The correct affiliation list is shown above.
  1 in total

1.  Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.

Authors:  Qi Yu; Changqing Xu; Wei Yuan; Chengfeng Wang; Ping Zhao; Lianzhen Chen; Jie Ma
Journal:  Biomed Res Int       Date:  2017-03-29       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.